Prellis is developing ultra-fast high-resolution holographic laser printing for creating human organs and tissues.
The two companies will advance the $1.2 million high-precision Holograph-X Bioprinter
Graphwear's wearable device employs an ultrathin layer of graphene in its sensor.
BillionToOne’s first product is a non-invasive prenatal test for recessively inherited single gene disorders.
The funding will help develop a novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics.
Under its new name, Tierra Biosciences, the company will focus on agricultural and biochemical products.
The so-called "Harrison rings" were used on five patients.